Crocs Inc. (CROX) 10.72 $CROX Crocs Inc. to Present at

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Crocs Inc. (CROX) 10.72 $CROX

Crocs Inc. to Present at the Baird 2016 Global Consumer, Technology and Services Conference
GlobeNewswire - Thu Jun 02, 3:05PM CDT
Crocs Inc. (NASDAQ:CROX) today announced that the Company will present at the Baird 2016 Global Consumer, Technology and Services Conference on June 8, 2016 at 10:15 am ET.
CROX: 10.72 (-0.05)

What Investors Make of These Stocks? - Iconix Brand, Crocs, Vera Bradley, and Steven Madden
PR Newswire - Thu Jun 02, 7:00AM CDT
In today's pre-market research, ActiveWallSt.com has directed our attention back on these four equities in the Textile and Apparel Footwear and Accessories industry: Iconix Brand Group Inc. (NASDAQ: ICON), Crocs Inc. (NASDAQ: CROX), Vera Bradley Inc. (NASDAQ: VRA), and Steven Madden Ltd (NASDAQ: SHOO). Click below to receive your free trade alerts on these stocks:
ICON: 7.71 (-0.44), SHOO: 34.10 (-0.56), CROX: 10.72 (-0.05), VRA: 14.36 (-0.65)

Crocs, Inc. Design Infringement Victory Awarded as Leading Intellectual Property Case in China
GlobeNewswire - Mon May 16, 3:00PM CDT
Crocs, Inc. (Nasdaq:CROX) today announced that a landmark ruling last year in the Shanghai Intermediate People's Court has been selected by China's Supreme People's Court as one of the top 50 leading IP cases of 2015, and also selected as one of the top 10 leading IP cases of the Shanghai Courts. These two announcements recognize the groundbreaking nature of the judgment, which protects the classic design of Crocs footwear in China.
CROX: 10.72 (-0.05)

Crocs tops Street 1Q forecasts
Automated Insights - Tue May 10, 6:45AM CDT
NIWOT, Colo. (AP) _ Crocs Inc. (CROX) on Tuesday reported first-quarter net income of $10.1 million, after reporting a loss in the same period a year earlier.
CROX: 10.72 (-0.05)

Crocs, Inc. Reports First Quarter 2016 Financial Results
GlobeNewswire - Tue May 10, 6:30AM CDT
Crocs, Inc. (NASDAQ:CROX) today reported financial results for the three months ended March 31, 2016.
CROX: 10.72 (-0.05)

Crocs "State of Fun" Survey Identifies Moms' Fun Deficit in Time for Mother's Day
GlobeNewswire - Mon May 02, 6:34AM CDT
Put down the smartphone and have fun in the moment this Mother's Day - American moms need more fun. The first-ever "State of Fun" survey commissioned by Crocs, Inc. (NASDAQ:CROX) shows that 90 percent of U.S. moms connect fun to their personal health and well being, yet 63 percent say they're having less fun today than they did 10 years ago.
CROX: 10.72 (-0.05)

Downgrade Alert for CROCS (CROX)
Comtex SmarTrend(R) - Thu Apr 28, 4:09AM CDT
CROCS (NASDAQ:CROX) was downgraded from Buy to Hold at Stifel today. The stock closed yesterday at $8.78 on volume of 2.4 million shares, above average daily volume of 676,000. In the past 52 weeks, CROCS share prices have been bracketed by a low of $8.09 and a high of $16.05 and closed yesterday at $8.78, 9% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has slid 0.7%.
CROX: 10.72 (-0.05)

Why Crocs, Inc. Shares Tumbled Today
Jeremy Bowman, The Motley Fool - Motley Fool - Wed Apr 27, 3:17PM CDT
What:  Shares of  Crocs were getting stepped on Wednesday after getting hit by an analyst downgrade. The stock was down 10.6% as of 2:31 p.m. EST. So what:  The struggling shoemaker slid after a Stifel analyst lowered his rating from buy to hold...
CROX: 10.72 (-0.05)

Travelport Worldwide, Crocs and Alphabet highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Mon Apr 25, 8:30AM CDT
Travelport Worldwide, Crocs and Alphabet highlighted as Zacks Bull and Bear of the Day
CROX: 10.72 (-0.05), TVPT: 13.13 (-0.38), GOOGL: 733.19 (-9.33)

Crocs, Inc. Announces Conference Call to Review First Quarter Fiscal 2016 Results
GlobeNewswire - Fri Apr 22, 6:30AM CDT
Crocs, Inc. (NASDAQ:CROX) today announced that it will host a conference call to discuss the results of its first quarter ended March 31, 2016 on Tuesday, May 10, 2016 at 8:30 a.m. EDT. The call participation number is (888) 771-4371. A replay of the conference call will be available two hours after the completion of the call at (888) 843-7419. International participants can dial (847) 585-4405 to take part in the conference call and can access a replay of the call at (630) 652-3042. All of the above calls will require the input of the conference identification number 42377507. The call also will be streamed on the Crocs website, www.crocs.com. An audio recording of the conference call will be available at www.crocs.com through May 10, 2017.
CROX: 10.72 (-0.05)

Why Stratasys, Crocs, and Synaptics Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Thu Apr 14, 5:13PM CDT
Image: Stratasys. After the big jump that the stock market has enjoyed during the first part of this week, Thursday's relatively quiet session came as no surprise to veteran market participants. The earliest part of the new earnings season has...
CROX: 10.72 (-0.05), SYNA: 61.36 (-2.40), DDD: 12.45 (-0.63), SSYS: 21.05 (-0.85)

Crocs, Inc. Expands Successful #FindYourFun Global Marketing Campaign
GlobeNewswire - Thu Mar 31, 3:00PM CDT
Crocs, Inc. (NASDAQ:CROX) today announced the continuation and expansion of its successful #FindYourFun global marketing campaign to reach more consumers in more ways in 2016.
CROX: 10.72 (-0.05)

Crocs (CROX) in Focus: Stock Adds 7.8% in Session
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 7:30AM CST
Crocs, Inc. (CROX) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
DLA: 21.97 (-0.18), CROX: 10.72 (-0.05)

BUYINS.NET: ZIOP, CROX, CVLT, ANW, HTS, NYMT Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Feb 09, 7:10AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Crocs Inc (NASDAQ:CROX), CommVault Systems Inc (NASDAQ:CVLT), Aegean Marine Petroleum Network Inc (NYSE:ANW), Hatteras Financial Corp (NYSE:HTS), New York Mortgage Trust Inc (NASDAQ:NYMT) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
ANW: 6.02 (-0.04), CROX: 10.72 (-0.05), ZIOP: 6.47 (-0.26), HTS: 16.28 (-0.04), CVLT: 46.19 (-1.05), NYMT: 6.33 (-0.01)

Weakness Seen in Crocs (CROX) Estimates: Should You Stay Away?
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 7:51AM CST
Crocs has an unfavorable Zacks Rank and the stock has been witnessing a significant price decline and negative earnings estimate revisions
CROX: 10.72 (-0.05), PERY: 20.22 (-0.47)

BUYINS.NET: PACB, SCHA, CROX, CODI, KALU, XPH Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Dec 31, 6:28AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Pacific Biosciences of California Inc (NASDAQACB), Schwab U S Small Cap ETF (NYSE:SCHA), Crocs Inc (NASDAQ:CROX), Compass Diversified Holdings (NYSE:CODI), Kaiser Aluminum Corp (NASDAQ:KALU), Spdr S&P Pharmaceuticals Etf (NYSE:XPH) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CODI: 16.25 (+0.04), CROX: 10.72 (-0.05), PACB: 9.56 (-0.24), KALU: 87.64 (-0.83), SCHA: 54.46 (-0.81), XPH: 43.46 (-0.83)

Watch for CROCS to Potentially Rebound After Falling 2.74% Yesterday
Comtex SmarTrend(R) - Mon Dec 28, 5:35PM CST
CROCS (NASDAQ:CROX) traded in a range yesterday that spanned from a low of $10.28 to a high of $10.63. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $10.32 on volume of 625,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CROX: 10.72 (-0.05)

Where Investors Are Going - Complementary Research on Crocs, Oncothyreon, Nimble Storage and Rexnord
ACCESSWIRE - Mon Dec 21, 6:45AM CST
NEW YORK, NY / ACCESSWIRE / December 21, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Crocs Inc. (NASDAQ: CROX), Oncothyreon Inc. (NASDAQ: ONTY), Nimble Storage Inc. (NYSE: NMBL) and Rexnord Corp. (NYSE: RXN). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
CROX: 10.72 (-0.05), NMBL: 8.52 (-0.26), RXN: 21.56 (-0.27), ONTY: 1.21 (+0.02)

Timing is Crucial, Upside Analysis - Analyst Reports on YRC Worldwide, Crocs, Oncothyreon and Nimble Storage
ACCESSWIRE - Thu Dec 10, 9:55AM CST
NEW YORK, NY / ACCESSWIRE / December 10, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: YRC Worldwide Inc. (NASDAQ: YRCW), Crocs Inc. (NASDAQ: CROX), Oncothyreon Inc. (NASDAQ: ONTY) and Nimble Storage Inc. (NYSE: NMBL). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
CROX: 10.72 (-0.05), NMBL: 8.52 (-0.26), ONTY: 1.21 (+0.02), YRCW: 9.01 (-0.30)

CROCS Down 21.8% Since SmarTrend Downtrend Call (CROX)
Comtex SmarTrend(R) - Mon Nov 23, 3:59PM CST
SmarTrend identified a Downtrend for CROCS (NASDAQ:CROX) on August 24th, 2015 at $13.62. In approximately 3 months, CROCS has returned 21.81% as of today's recent price of $10.65.
CROX: 10.72 (-0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First Industrial Declares Regular Dividend Amid Growth Insights

Updated Category News Views 75

Dividend Declaration Reflects Confidence First Industrial Realty Trust, folks, just put another office stamp on their ongoing reliability quest—and I'm talking dividends. They're shelling out a tidy $0.50 per share for Q4 2026, with stockholders due to see the cash on January 19, 2027. That's like clockwork precision, showing a steadiness in what some call the unruly...

Continue Reading
Trimble's Q3 2026: Guidance Update and Record ARR

Updated Category News Views 48

Trimble Smashes Through Q3 Expectations Trimble Inc. (NASDAQ:TRMB) tossed a bit of a curveball by posting Q3 2026 results that sailed past analyst forecasts. We’re talking revenue swelling to $966.8 million, a decent 7% bump from the previous year. Now, for a company riding its 'Connect & Scale' strategy, this serves as a validation of its aggressive scaling ambitions....

Continue Reading
Fractal Sees Explosive Q2 Gain: Revenue Hits $100M

Updated Category News Views 93

Fractal’s Revenue Moment: Climbing New Peaks Fractal Analytics just knocked it out of the park, folks. Imagine this—an AI company pulling in $100 million for the first quarter, getting a 20% jump in revenue year on year. That's right, these numbers aren't just fancy figures; they're staggering proof that Fractal's hitting its AI stride. The healthcare and life...

Continue Reading
Zuellig Pharma Expands Clinical Capabilities in China

Updated Category News Views 86

Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...

Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes

Updated Category News Views 56

Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...

Continue Reading
VAB's Pharma Ad Guide: Emerging Trends and Insights

Updated Category News Views 191

Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...

Continue Reading
Coretek Joins CRN's Elite AI Innovators of 2026

Updated Category News Views 69

Coretek's Leap to AI Innovator Status Here we are, folks. Another announcement hits the wires that showcases a company's ascent amid the swelling AI tide. Coretek, hailing from Farmington Hills, managed to snag a spot on CRN's inaugural 2026 AI Innovators list. No small potatoes, if you ask me, considering the competition on this playing field. Why the fuss? It's about...

Continue Reading
Allego Dominates 2026 Gartner Magic Quadrant: Why It Matters

Updated Category News Views 40

Allego Secures Top Spot Yet Again I've seen companies rise and fall on the whims of industry recognition, and let me tell ya, Allego's riding high on the right wave. For the second year running, this outfit's been named a Leader in the 2026 Gartner Magic Quadrant for Revenue Enablement Platforms. Recognized for its Completeness of Vision—yeah, that's no small feat...

Continue Reading
KOVE's Bold Lineup Expansion at EICMA 2026

Updated Category News Views 112

What's Roaring: The Latest from KOVE Anybody who’s been following motorcycle trends knows that EICMA 2026 was destined to be a spectacle, and KOVE didn’t disappoint. They rolled out a fleet of five new models, including the 125 RALLY, 350 RALLY, 650RR, and two head-turners on the electric front: the BONIC and the E-500RR. Each model brings something fresh to the...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 6

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading

Top 5 Most Recently Viewed Articles

Tesla's Earnings Impact: A Preview for Investors Ahead

Updated Category News Views 206

Tesla's Earnings and Market Dynamics As we gear up for Tesla's earnings announcement, all eyes are turning to the electric vehicle giant (NASDAQ: TSLA). Tesla is leading the charge as the first among the prominent group of tech companies known as the "Magnificent Seven" to reveal its financial performance. The anticipation builds as markets reflect on how business...

Continue Reading
Atos Group Releases Detailed Half-Year Financial Report for 2025

Updated Category News Views 222

Atos Group Updates on Financial Performance for 2025 Availability of the 2025 Half-year Financial Report Atos Group has made significant strides in its financial reporting for 2025, announcing the release of its half-year financial report. This document was published on the Atos website and was also filed with the French Financial Markets Authority (AMF). Insights from...

Continue Reading
Anywhere Real Estate and Canva Team Up for Agents' Success

Updated Category News Views 204

Anywhere Real Estate's Exciting New Partnership Anywhere Real Estate Inc. (NYSE: HOUS), a global frontrunner in the residential real estate sector, has recently unveiled an impactful collaboration with Canva, a recognized visual communication platform. This agreement aims to empower Every agent within their extensive network. Enhanced Tools for Affiliated Agents This...

Continue Reading
THEON Showcases Innovative A.R.M.E.D. Ecosystem at IDEX 2025

Updated Category News Views 279

THEON Unveils Revolutionary A.R.M.E.D. Ecosystem At IDEX 2025, THEON made a significant impact by showcasing its A.R.M.E.D. (Augmented Reality Modular Ecosystem of Devices), designed to elevate the capabilities of tomorrow's soldiers. This integrated solution promises to improve tactical awareness, effectiveness, and survivability for modern combat operatives....

Continue Reading
Exploring Advances in Arthrogryposis at Montreal Symposium

Updated Category News Views 304

4th International Symposium on Arthrogryposis Unveiled in Montreal MONTREAL — The Shriners Hospitals for Children - Canada is set to host the much-anticipated 4th International Symposium on Arthrogryposis from September 28 to October 1. This initiative brings together renowned healthcare professionals and researchers from various pediatric centers in Montreal,...

Continue Reading